Table 3 Baseline characteristics (median (IQR)) of women with proteinuria at follow-up
From: Short term sequelae of preeclampsia: a single center cohort study
No UPE (n = 134) | UPE > 0.11 (n = 66) | p-value | No UPE (n = 184) | UPE ≥30 (n = 16) | p-value | |
|---|---|---|---|---|---|---|
Age | 31 (28–35) | 35 (28–38) | 0.16 | 32 (29–36) | 34 (25–38) | 0.80 |
Onset (d) | 260 (238–272) | 258 (246–272) | 0.61 | 259 (240–272) | 266 (248–279) | 0.29 |
Early onset | 24.8% (32/129) | 14.1% (9/64) | 0.09 | 22.6% (40/177) | 6.25% (1/16) | 0.13 |
Nulliparous | 75.2% (100/133) | 73.9% (48/65) | 0.84 | 73.6% (134/182) | 87.5% (14/16) | 0.22 |
Time to f/u (d) | 183 (157–191) | 172 (138–187) | 0.06 | 180 (154–190) | 160 (114–195) | 0.42 |
MP | 12.7% (17/134) | 15.2% (10/66) | 0.61 | 14.1% (26/184) | 6.3% (1/16) | 0.34 |
IVF | 4.5% (6/134) | 10.6% (7/66) | 0.10 | 6.5%(12/184) | 6.3% (1/16) | 0.97 |
GD | 7.5% (10/134) | 16.7% (9/66) | 0.16 | 8.2%(15/184) | 25.0% (4/16) | 0.02 |
HELLP | 22.7% (30/132) | 16.9% (11/65) | 0.35 | 22.1% (40/181) | 6.3% (1/16) | 0.13 |
Severe | 67.2% (88/131) | 66.2%(43/65) | 0.89 | 66.1% (119/180) | 75% (12/16) | 0.45 |
AKI | 9.9% (13/131) | 6.2%(4/65) | 0.34 | 8.3% (15/180) | 12.5% (2/16) | 0.57 |